Healthtech Startups
15,470 companies tagged Healthtech, with their investors and founders.
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems. It serves healthcare providers in the neurodiagnostics and medical device field.
4 investors
4 investors
Chapter provides Medicare plan comparison and advisory services to help seniors choose the best health insurance coverage. The platform connects retirees with advisors who evaluate nationwide Medicare plans and recommend personalized options based on individual needs.
4 investors
Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease. The company builds its technology together with and for Parkinson's patients based on ongoing scientific research.
4 investors
CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches. It applies AI and structure-based drug discovery to design potent inhibitors targeting protein-ligand interactions at the KMT2A interface on menin.
4 investors
Cherry is a point-of-sale financing platform that enables healthcare practices to offer patients buy-now-pay-later payment plans with instant approval and competitive rates.
4 investors
4 investors
Ciba Health offers an AI-powered virtual platform for managing and reversing chronic conditions such as type 2 diabetes, obesity, metabolic dysfunction, GI, autoimmune, and mental health issues. It serves employers, health plans, health systems, and individual members, using predictive analytics and clinical care teams to lower medical and pharmacy costs.
4 investors
Cipher Surgical makes OpClear, a laparoscopic scope lens cleaning device consisting of a control unit and a sheath that attaches to the scope, delivering automated CO2 flow to reduce fog and on-demand saline lens wash for continuous intra-abdominal vision. It is designed for laparoscopic surgeons across specialties such as general, bariatric, gynecology, urology, and colorectal surgery, and is compatible with most major laparoscopic instrument brands.
4 investors
Citryll is a biotech company developing CIT-013, a first-in-class monoclonal antibody that targets Extracellular Traps (ETs) to treat immune-mediated inflammatory diseases, with a focus on rheumatoid arthritis and hidradenitis suppurativa. The company runs clinical trials for its ET-targeting therapy aimed at resolving inflammation.
4 investors
ClaimBuddy provides health insurance claim assistance for patients and hospitals in India, helping check claim eligibility, arrange documentation, and file claims to reduce rejections. It operates through on-site claim staff at hospital desks and technology-driven processes.
4 investors
Clarify Health is a healthcare outcomes and analytics company that partners with health systems to align clinical, access, and financial performance across referrals, network economics, and payer contracts. It works with over 60 health systems, using patient journey and price transparency data to inform decisions on referrals, contracts, and service lines.
4 investors
ClearDATA is a cloud security and compliance platform purpose-built for healthcare organizations. It provides cloud security posture management (CSPM) software to prevent, detect, and remediate compliance drift and sensitive data gaps across AWS, Azure, and Google Cloud Platform, with expertise in HIPAA, HITRUST, and GDPR regulations.
4 investors
CRIO develops eSource software for clinical research sites to manage electronic source documentation and trial workflows. The platform serves research sites, sponsors, and CROs in the clinical trials industry.
4 investors
Clivi provides an online medical treatment service in Mexico, combining virtual evaluations, laboratory tests, physician consultations, home medication delivery, and app-based progress tracking. It offers personalized care protocols for patients managing health conditions and weight-related goals, with 24/7 medical support.
4 investors
CloudCruise provides an AI-powered platform for building and running browser automations, particularly for healthcare workflows like EHR and payer portal integrations. The platform handles script generation, execution management, error recovery, and infrastructure, with built-in HIPAA compliance and stealth features for healthcare automation.
4 investors
Coave Therapeutics is a biotech company developing gene therapies based on AAV vector engineering and genetic construct design, targeting neurodegenerative and ocular diseases. It is developing OneAAV, a universal capsid intended for next-generation gene therapy vectors.
4 investors
Coding Bio develops modular immunotherapies for cancer patients, using a high-throughput lab to screen millions of protein candidates in living cells and a machine learning platform to design and optimize therapies for immune activation. The company operates in the immuno-oncology and cell therapy space, aiming to accelerate development of CAR and related therapies.
4 investors
Codoxo builds a generative AI-driven Unified Cost Containment Platform for healthcare payers, government agencies, and pharmacy benefit managers to improve payment integrity and detect fraud, waste, and abuse. The platform shifts cost containment earlier in the claims cycle through pre-claim provider education, prepayment and postpayment auditing, and Special Investigation Unit services.
4 investors
Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers. It targets neurodegenerative diseases including dementia with Lewy bodies (DLB) and Alzheimer's disease.
4 investors
Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer. The company focuses on expanding its pipeline of clinical-stage candidates targeting the tumor microenvironment.
4 investors
Colla Health provides a behavioral health program for cancer patients, staffing clinicians with psycho-oncology training who deliver evidence-based therapies such as CBT and ACT. It serves community oncology practices and cancer centers across the United States.
4 investors
Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women. It focuses on evidence-based therapies for life-threatening complications of pregnancy.
4 investors
Comind is developing non-invasive neurotechnology that measures a range of neurophysiological brain signals in a single bedside measurement. The technology is aimed at doctors and clinical care settings to support patient assessment and treatment.
4 investors